-DOCSTART- -X- -X- O

Clustering NN NN O
of NN NN O
missense NN NN O
mutations NN NN O
in NN NN O
the NN NN O
ataxia-telangiectasia NN NN B-Modifier
gene NN NN O
in NN NN O
a NN NN O
sporadic NN NN B-SpecificDisease
T-cell NN NN I-SpecificDisease
leukaemia NN NN I-SpecificDisease
. NN NN O

Myotonic NN NN B-Modifier
dystrophy NN NN I-Modifier
protein NN NN O
kinase NN NN O
is NN NN O
involved NN NN O
in NN NN O
the NN NN O
modulation NN NN O
of NN NN O
the NN NN O
Ca2+ NN NN O
homeostasis NN NN O
in NN NN O
skeletal NN NN O
muscle NN NN O
cells NN NN O
. NN NN O

Constitutional NN NN O
RB1-gene NN NN O
mutations NN NN O
in NN NN O
patients NN NN O
with NN NN O
isolated NN NN O
unilateral NN NN B-SpecificDisease
retinoblastoma NN NN I-SpecificDisease
. NN NN O

Hereditary NN NN B-SpecificDisease
deficiency NN NN I-SpecificDisease
of NN NN I-SpecificDisease
the NN NN I-SpecificDisease
fifth NN NN I-SpecificDisease
component NN NN I-SpecificDisease
of NN NN I-SpecificDisease
complement NN NN I-SpecificDisease
in NN NN O
man NN NN O
. NN NN O

I NN NN O
. NN NN O
Clinical NN NN O
, NN NN O
immunochemical NN NN O
, NN NN O
and NN NN O
family NN NN O
studies NN NN O
. NN NN O

Susceptibility NN NN O
to NN NN O
ankylosing NN NN B-SpecificDisease
spondylitis NN NN I-SpecificDisease
in NN NN O
twins NN NN O
: NN NN O
the NN NN O
role NN NN O
of NN NN O
genes NN NN O
, NN NN O
HLA NN NN O
, NN NN O
and NN NN O
the NN NN O
environment NN NN O
. NN NN O

Cell NN NN O
cycle-dependent NN NN O
colocalization NN NN O
of NN NN O
BARD1 NN NN O
and NN NN O
BRCA1 NN NN O
proteins NN NN O
in NN NN O
discrete NN NN O
nuclear NN NN O
domains NN NN O
. NN NN O

Ethnic NN NN O
differences NN NN O
in NN NN O
the NN NN O
HFE NN NN O
codon NN NN O
282 NN NN O
( NN NN O
Cys/Tyr NN NN O
) NN NN O
polymorphism NN NN O
. NN NN O

Autosomal NN NN B-SpecificDisease
dominant NN NN I-SpecificDisease
neurohypophyseal NN NN I-SpecificDisease
diabetes NN NN I-SpecificDisease
insipidus NN NN I-SpecificDisease
associated NN NN O
with NN NN O
a NN NN O
missense NN NN O
mutation NN NN O
encoding NN NN O
Gly23-->Val NN NN O
in NN NN O
neurophysin NN NN O
II NN NN O
. NN NN O

Frequent NN NN O
inactivation NN NN O
of NN NN O
PTEN/MMAC1 NN NN O
in NN NN O
primary NN NN O
prostate NN NN B-SpecificDisease
cancer NN NN I-SpecificDisease
. NN NN O

Risk NN NN O
reversals NN NN O
in NN NN O
predictive NN NN O
testing NN NN O
for NN NN O
Huntington NN NN B-SpecificDisease
disease NN NN I-SpecificDisease
. NN NN O

A NN NN O
novel NN NN O
common NN NN O
missense NN NN O
mutation NN NN O
G301C NN NN O
in NN NN O
the NN NN O
N-acetylgalactosamine-6-sulfate NN NN O
sulfatase NN NN O
gene NN NN O
in NN NN O
mucopolysaccharidosis NN NN B-SpecificDisease
IVA NN NN I-SpecificDisease
. NN NN O

Low NN NN O
frequency NN NN O
of NN NN O
BRCA1 NN NN O
germline NN NN O
mutations NN NN O
in NN NN O
45 NN NN O
German NN NN O
breast/ovarian NN NN B-Modifier
cancer NN NN I-Modifier
families NN NN O
. NN NN O

Paternal NN NN O
transmission NN NN O
of NN NN O
congenital NN NN B-SpecificDisease
myotonic NN NN I-SpecificDisease
dystrophy NN NN I-SpecificDisease
. NN NN O

The NN NN O
RB1 NN NN O
gene NN NN O
mutation NN NN O
in NN NN O
a NN NN O
child NN NN O
with NN NN O
ectopic NN NN B-SpecificDisease
intracranial NN NN I-SpecificDisease
retinoblastoma NN NN I-SpecificDisease
. NN NN O

Low NN NN O
levels NN NN O
of NN NN O
beta NN NN O
hexosaminidase NN NN O
A NN NN O
in NN NN O
healthy NN NN O
individuals NN NN O
with NN NN O
apparent NN NN O
deficiency NN NN O
of NN NN O
this NN NN O
enzyme NN NN O
. NN NN O

The NN NN O
tumor NN NN B-Modifier
suppressor NN NN O
gene NN NN O
Smad4/Dpc4 NN NN O
is NN NN O
required NN NN O
for NN NN O
gastrulation NN NN O
and NN NN O
later NN NN O
for NN NN O
anterior NN NN O
development NN NN O
of NN NN O
the NN NN O
mouse NN NN O
embryo NN NN O
. NN NN O

Prevalence NN NN O
of NN NN O
p16 NN NN O
and NN NN O
CDK4 NN NN O
germline NN NN O
mutations NN NN O
in NN NN O
48 NN NN O
melanoma NN NN B-Modifier
- NN NN O
prone NN NN O
families NN NN O
in NN NN O
France NN NN O
. NN NN O

The NN NN O
French NN NN O
Familial NN NN B-Modifier
Melanoma NN NN I-Modifier
Study NN NN O
Group NN NN O
. NN NN O

Progression NN NN O
of NN NN O
somatic NN NN O
CTG NN NN O
repeat NN NN O
length NN NN O
heterogeneity NN NN O
in NN NN O
the NN NN O
blood NN NN O
cells NN NN O
of NN NN O
myotonic NN NN B-Modifier
dystrophy NN NN I-Modifier
patients NN NN O
. NN NN O

Aspartylglucosaminuria NN NN B-SpecificDisease
among NN NN O
Palestinian NN NN O
Arabs NN NN O
. NN NN O

Detection NN NN O
of NN NN O
heterozygous NN NN O
carriers NN NN O
of NN NN O
the NN NN O
ataxia-telangiectasia NN NN B-Modifier
( NN NN O
ATM NN NN O
) NN NN O
gene NN NN O
by NN NN O
G2 NN NN O
phase NN NN O
chromosomal NN NN O
radiosensitivity NN NN O
of NN NN O
peripheral NN NN O
blood NN NN O
lymphocytes NN NN O
. NN NN O

Ataxia-telangiectasia NN NN B-SpecificDisease
: NN NN O
identification NN NN O
and NN NN O
detection NN NN O
of NN NN O
founder-effect NN NN O
mutations NN NN O
in NN NN O
the NN NN O
ATM NN NN O
gene NN NN O
in NN NN O
ethnic NN NN O
populations NN NN O
. NN NN O

The NN NN O
von NN NN B-Modifier
Hippel-Lindau NN NN I-Modifier
tumor NN NN I-Modifier
suppressor NN NN O
gene NN NN O
is NN NN O
required NN NN O
for NN NN O
cell NN NN O
cycle NN NN O
exit NN NN O
upon NN NN O
serum NN NN O
withdrawal NN NN O
. NN NN O

Piebaldism NN NN B-SpecificDisease
with NN NN O
deafness NN NN B-SpecificDisease
: NN NN O
molecular NN NN O
evidence NN NN O
for NN NN O
an NN NN O
expanded NN NN O
syndrome NN NN O
. NN NN O

Cycloheximide NN NN O
facilitates NN NN O
the NN NN O
identification NN NN O
of NN NN O
aberrant NN NN O
transcripts NN NN O
resulting NN NN O
from NN NN O
a NN NN O
novel NN NN O
splice-site NN NN O
mutation NN NN O
in NN NN O
COL17A1 NN NN O
in NN NN O
a NN NN O
patient NN NN O
with NN NN O
generalized NN NN O
atrophic NN NN B-SpecificDisease
benign NN NN I-SpecificDisease
epidermolysis NN NN I-SpecificDisease
bullosa NN NN I-SpecificDisease
. NN NN O

A NN NN O
deletion NN NN O
mutation NN NN O
in NN NN O
COL17A1 NN NN O
in NN NN O
five NN NN O
Austrian NN NN O
families NN NN O
with NN NN O
generalized NN NN O
atrophic NN NN B-SpecificDisease
benign NN NN I-SpecificDisease
epidermolysis NN NN I-SpecificDisease
bullosa NN NN I-SpecificDisease
represents NN NN O
propagation NN NN O
of NN NN O
an NN NN O
ancestral NN NN O
allele NN NN O
. NN NN O

The NN NN O
haptoglobin-gene NN NN O
deletion NN NN O
responsible NN NN O
for NN NN O
anhaptoglobinemia NN NN B-SpecificDisease
. NN NN O

ATM NN NN O
mutations NN NN O
and NN NN O
phenotypes NN NN O
in NN NN O
ataxia-telangiectasia NN NN B-Modifier
families NN NN O
in NN NN O
the NN NN O
British NN NN O
Isles NN NN O
: NN NN O
expression NN NN O
of NN NN O
mutant NN NN O
ATM NN NN O
and NN NN O
the NN NN O
risk NN NN O
of NN NN O
leukemia NN NN B-SpecificDisease
, NN NN O
lymphoma NN NN B-SpecificDisease
, NN NN O
and NN NN O
breast NN NN B-SpecificDisease
cancer NN NN I-SpecificDisease
. NN NN O

The NN NN O
DMPK NN NN O
gene NN NN O
of NN NN O
severely NN NN O
affected NN NN O
myotonic NN NN B-Modifier
dystrophy NN NN I-Modifier
patients NN NN O
is NN NN O
hypermethylated NN NN O
proximal NN NN O
to NN NN O
the NN NN O
largely NN NN O
expanded NN NN O
CTG NN NN O
repeat NN NN O
. NN NN O

The NN NN O
hemochromatosis NN NN B-Modifier
gene NN NN O
product NN NN O
complexes NN NN O
with NN NN O
the NN NN O
transferrin NN NN O
receptor NN NN O
and NN NN O
lowers NN NN O
its NN NN O
affinity NN NN O
for NN NN O
ligand NN NN O
binding NN NN O
. NN NN O

Genomic NN NN O
organization NN NN O
of NN NN O
the NN NN O
UBE3A/E6-AP NN NN O
gene NN NN O
and NN NN O
related NN NN O
pseudogenes NN NN O
. NN NN O

Mutation NN NN O
spectrum NN NN O
and NN NN O
genotype-phenotype NN NN O
analyses NN NN O
in NN NN O
Cowden NN NN B-SpecificDisease
disease NN NN I-SpecificDisease
and NN NN O
Bannayan-Zonana NN NN B-SpecificDisease
syndrome NN NN I-SpecificDisease
, NN NN O
two NN NN O
hamartoma NN NN B-DiseaseClass
syndromes NN NN I-DiseaseClass
with NN NN O
germline NN NN O
PTEN NN NN O
mutation NN NN O
. NN NN O

Molecular NN NN O
defects NN NN O
leading NN NN O
to NN NN O
human NN NN O
complement NN NN B-SpecificDisease
component NN NN I-SpecificDisease
C6 NN NN I-SpecificDisease
deficiency NN NN I-SpecificDisease
in NN NN O
an NN NN O
African-American NN NN O
family NN NN O
. NN NN O

PAX6 NN NN O
mutations NN NN O
reviewed NN NN O
. NN NN O

Genetic NN NN O
heterogeneity NN NN O
and NN NN O
penetrance NN NN O
analysis NN NN O
of NN NN O
the NN NN O
BRCA1 NN NN O
and NN NN O
BRCA2 NN NN O
genes NN NN O
in NN NN O
breast NN NN B-Modifier
cancer NN NN I-Modifier
families NN NN O
. NN NN O

The NN NN O
Breast NN NN B-Modifier
Cancer NN NN I-Modifier
Linkage NN NN O
Consortium NN NN O
. NN NN O

Eye NN NN B-DiseaseClass
movement NN NN I-DiseaseClass
abnormalities NN NN I-DiseaseClass
correlate NN NN O
with NN NN O
genotype NN NN O
in NN NN O
autosomal NN NN O
dominant NN NN O
cerebellar NN NN B-DiseaseClass
ataxia NN NN I-DiseaseClass
type NN NN I-DiseaseClass
I NN NN I-DiseaseClass
. NN NN O

Genetic NN NN O
basis NN NN O
and NN NN O
molecular NN NN O
mechanism NN NN O
for NN NN O
idiopathic NN NN B-SpecificDisease
ventricular NN NN I-SpecificDisease
fibrillation NN NN I-SpecificDisease
. NN NN O

Molecular NN NN O
heterogeneity NN NN O
in NN NN O
mucopolysaccharidosis NN NN B-SpecificDisease
IVA NN NN I-SpecificDisease
in NN NN O
Australia NN NN O
and NN NN O
Northern NN NN O
Ireland NN NN O
: NN NN O
nine NN NN O
novel NN NN O
mutations NN NN O
including NN NN O
T312S NN NN O
, NN NN O
a NN NN O
common NN NN O
allele NN NN O
that NN NN O
confers NN NN O
a NN NN O
mild NN NN O
phenotype NN NN O
. NN NN O

Identification NN NN O
of NN NN O
constitutional NN NN O
WT1 NN NN O
mutations NN NN O
, NN NN O
in NN NN O
patients NN NN O
with NN NN O
isolated NN NN O
diffuse NN NN B-SpecificDisease
mesangial NN NN I-SpecificDisease
sclerosis NN NN I-SpecificDisease
, NN NN O
and NN NN O
analysis NN NN O
of NN NN O
genotype/phenotype NN NN O
correlations NN NN O
by NN NN O
use NN NN O
of NN NN O
a NN NN O
computerized NN NN O
mutation NN NN O
database NN NN O
. NN NN O

The NN NN O
185delAG NN NN O
BRCA1 NN NN O
mutation NN NN O
originated NN NN O
before NN NN O
the NN NN O
dispersion NN NN O
of NN NN O
Jews NN NN O
in NN NN O
the NN NN O
diaspora NN NN O
and NN NN O
is NN NN O
not NN NN O
limited NN NN O
to NN NN O
Ashkenazim NN NN O
. NN NN O

Crystal NN NN O
structure NN NN O
of NN NN O
the NN NN O
hemochromatosis NN NN B-Modifier
protein NN NN O
HFE NN NN O
and NN NN O
characterization NN NN O
of NN NN O
its NN NN O
interaction NN NN O
with NN NN O
transferrin NN NN O
receptor NN NN O
. NN NN O

Identification NN NN O
of NN NN O
three NN NN O
novel NN NN O
mutations NN NN O
and NN NN O
a NN NN O
high NN NN O
frequency NN NN O
of NN NN O
the NN NN O
Arg778Leu NN NN O
mutation NN NN O
in NN NN O
Korean NN NN O
patients NN NN O
with NN NN O
Wilson NN NN B-SpecificDisease
disease NN NN I-SpecificDisease
. NN NN O

Disruption NN NN O
of NN NN O
splicing NN NN O
regulated NN NN O
by NN NN O
a NN NN O
CUG-binding NN NN O
protein NN NN O
in NN NN O
myotonic NN NN B-SpecificDisease
dystrophy NN NN I-SpecificDisease
. NN NN O

Identification NN NN O
of NN NN O
a NN NN O
novel NN NN O
nonsense NN NN O
mutation NN NN O
and NN NN O
a NN NN O
missense NN NN O
substitution NN NN O
in NN NN O
the NN NN O
vasopressin-neurophysin NN NN O
II NN NN O
gene NN NN O
in NN NN O
two NN NN O
Spanish NN NN O
kindreds NN NN O
with NN NN O
familial NN NN B-SpecificDisease
neurohypophyseal NN NN I-SpecificDisease
diabetes NN NN I-SpecificDisease
insipidus NN NN I-SpecificDisease
. NN NN O

Genetic NN NN O
heterogeneity NN NN O
of NN NN O
Saethre-Chotzen NN NN B-SpecificDisease
syndrome NN NN I-SpecificDisease
, NN NN O
due NN NN O
to NN NN O
TWIST NN NN O
and NN NN O
FGFR NN NN O
mutations NN NN O
. NN NN O

Mutation NN NN O
analysis NN NN O
of NN NN O
UBE3A NN NN O
in NN NN O
Angelman NN NN B-Modifier
syndrome NN NN I-Modifier
patients NN NN O
. NN NN O

The NN NN O
hemochromatosis NN NN B-Modifier
845 NN NN O
G-->A NN NN O
and NN NN O
187 NN NN O
C-->G NN NN O
mutations NN NN O
: NN NN O
prevalence NN NN O
in NN NN O
non-Caucasian NN NN O
populations NN NN O
. NN NN O

Genotype-phenotype NN NN O
correlations NN NN O
in NN NN O
attenuated NN NN B-SpecificDisease
adenomatous NN NN I-SpecificDisease
polyposis NN NN I-SpecificDisease
coli NN NN I-SpecificDisease
. NN NN O

Wilms NN NN B-Modifier
' NN NN I-Modifier
tumor NN NN I-Modifier
1 NN NN O
and NN NN O
Dax-1 NN NN O
modulate NN NN O
the NN NN O
orphan NN NN O
nuclear NN NN O
receptor NN NN O
SF-1 NN NN O
in NN NN O
sex-specific NN NN O
gene NN NN O
expression NN NN O
. NN NN O

A NN NN O
mouse NN NN O
model NN NN O
for NN NN O
Prader-Willi NN NN B-SpecificDisease
syndrome NN NN I-SpecificDisease
imprinting-centre NN NN O
mutations NN NN O
. NN NN O

Mutations NN NN O
of NN NN O
the NN NN O
ATM NN NN O
gene NN NN O
detected NN NN O
in NN NN O
Japanese NN NN O
ataxia-telangiectasia NN NN B-Modifier
patients NN NN O
: NN NN O
possible NN NN O
preponderance NN NN O
of NN NN O
the NN NN O
two NN NN O
founder NN NN O
mutations NN NN O
4612del165 NN NN O
and NN NN O
7883del5 NN NN O
. NN NN O

W474C NN NN O
amino NN NN O
acid NN NN O
substitution NN NN O
affects NN NN O
early NN NN O
processing NN NN O
of NN NN O
the NN NN O
alpha-subunit NN NN O
of NN NN O
beta-hexosaminidase NN NN O
A NN NN O
and NN NN O
is NN NN O
associated NN NN O
with NN NN O
subacute NN NN O
G(M2 NN NN B-SpecificDisease
) NN NN I-SpecificDisease
gangliosidosis NN NN I-SpecificDisease
. NN NN O

Two NN NN O
frequent NN NN O
missense NN NN O
mutations NN NN O
in NN NN O
Pendred NN NN B-SpecificDisease
syndrome NN NN I-SpecificDisease
. NN NN O

Insertional NN NN O
mutation NN NN O
by NN NN O
transposable NN NN O
element NN NN O
, NN NN O
L1 NN NN O
, NN NN O
in NN NN O
the NN NN O
DMD NN NN B-Modifier
gene NN NN O
results NN NN O
in NN NN O
X-linked NN NN B-SpecificDisease
dilated NN NN I-SpecificDisease
cardiomyopathy NN NN I-SpecificDisease
. NN NN O

Severe NN NN O
early-onset NN NN O
obesity NN NN B-SpecificDisease
, NN NN O
adrenal NN NN B-DiseaseClass
insufficiency NN NN I-DiseaseClass
and NN NN O
red NN NN O
hair NN NN O
pigmentation NN NN O
caused NN NN O
by NN NN O
POMC NN NN O
mutations NN NN O
in NN NN O
humans NN NN O
. NN NN O

A NN NN O
European NN NN O
multicenter NN NN O
study NN NN O
of NN NN O
phenylalanine NN NN B-SpecificDisease
hydroxylase NN NN I-SpecificDisease
deficiency NN NN I-SpecificDisease
: NN NN O
classification NN NN O
of NN NN O
105 NN NN O
mutations NN NN O
and NN NN O
a NN NN O
general NN NN O
system NN NN O
for NN NN O
genotype-based NN NN O
prediction NN NN O
of NN NN O
metabolic NN NN O
phenotype NN NN O
. NN NN O

Somatic NN NN O
instability NN NN O
of NN NN O
the NN NN O
CTG NN NN O
repeat NN NN O
in NN NN O
mice NN NN O
transgenic NN NN O
for NN NN O
the NN NN O
myotonic NN NN B-Modifier
dystrophy NN NN I-Modifier
region NN NN O
is NN NN O
age NN NN O
dependent NN NN O
but NN NN O
not NN NN O
correlated NN NN O
to NN NN O
the NN NN O
relative NN NN O
intertissue NN NN O
transcription NN NN O
levels NN NN O
and NN NN O
proliferative NN NN O
capacities NN NN O
. NN NN O

A NN NN O
novel NN NN O
missense NN NN O
mutation NN NN O
in NN NN O
patients NN NN O
from NN NN O
a NN NN O
retinoblastoma NN NN B-Modifier
pedigree NN NN O
showing NN NN O
only NN NN O
mild NN NN O
expression NN NN O
of NN NN O
the NN NN O
tumor NN NN B-Modifier
phenotype NN NN O
. NN NN O

Maternal NN NN B-DiseaseClass
disomy NN NN I-DiseaseClass
and NN NN O
Prader-Willi NN NN B-SpecificDisease
syndrome NN NN I-SpecificDisease
consistent NN NN O
with NN NN O
gamete NN NN O
complementation NN NN O
in NN NN O
a NN NN O
case NN NN O
of NN NN O
familial NN NN O
translocation NN NN O
( NN NN O
3 NN NN O
; NN NN O

15 NN NN O
) NN NN O
( NN NN O
p25 NN NN O
; NN NN O

q11.2 NN NN O
). NN NN O

Schwartz-Jampel NN NN B-SpecificDisease
syndrome NN NN I-SpecificDisease
type NN NN I-SpecificDisease
2 NN NN I-SpecificDisease
and NN NN O
Stuve-Wiedemann NN NN B-SpecificDisease
syndrome NN NN I-SpecificDisease
: NN NN O
a NN NN O
case NN NN O
for NN NN O
" NN NN O
lumping NN NN O
". NN NN O

A NN NN O
mouse NN NN O
model NN NN O
of NN NN O
severe NN NN O
von NN NN B-SpecificDisease
Willebrand NN NN I-SpecificDisease
disease NN NN I-SpecificDisease
: NN NN O
defects NN NN O
in NN NN O
hemostasis NN NN O
and NN NN O
thrombosis NN NN B-SpecificDisease
. NN NN O

Oral NN NN O
contraceptives NN NN O
and NN NN O
the NN NN O
risk NN NN O
of NN NN O
hereditary NN NN B-SpecificDisease
ovarian NN NN I-SpecificDisease
cancer NN NN I-SpecificDisease
. NN NN O

Hereditary NN NN B-Modifier
Ovarian NN NN I-Modifier
Cancer NN NN I-Modifier
Clinical NN NN O
Study NN NN O
Group NN NN O
. NN NN O

A NN NN O
Japanese NN NN O
family NN NN O
with NN NN O
adrenoleukodystrophy NN NN B-SpecificDisease
with NN NN O
a NN NN O
codon NN NN O
291 NN NN O
deletion NN NN O
: NN NN O
a NN NN O
clinical NN NN O
, NN NN O
biochemical NN NN O
, NN NN O
pathological NN NN O
, NN NN O
and NN NN O
genetic NN NN O
report NN NN O
. NN NN O

Nonsense NN NN O
mutation NN NN O
in NN NN O
exon NN NN O
4 NN NN O
of NN NN O
human NN NN O
complement NN NN O
C9 NN NN O
gene NN NN O
is NN NN O
the NN NN O
major NN NN O
cause NN NN O
of NN NN O
Japanese NN NN O
complement NN NN B-SpecificDisease
C9 NN NN I-SpecificDisease
deficiency NN NN I-SpecificDisease
. NN NN O

BRCA1 NN NN O
required NN NN O
for NN NN O
transcription-coupled NN NN O
repair NN NN O
of NN NN O
oxidative NN NN O
DNA NN NN O
damage NN NN O
. NN NN O

Truncation NN NN O
mutations NN NN O
in NN NN O
the NN NN O
transactivation NN NN O
region NN NN O
of NN NN O
PAX6 NN NN O
result NN NN O
in NN NN O
dominant-negative NN NN O
mutants NN NN O
. NN NN O

Reversal NN NN O
of NN NN O
severe NN NN O
hypertrophic NN NN B-SpecificDisease
cardiomyopathy NN NN I-SpecificDisease
and NN NN O
excellent NN NN O
neuropsychologic NN NN O
outcome NN NN O
in NN NN O
very-long-chain NN NN B-SpecificDisease
acyl-coenzyme NN NN I-SpecificDisease
A NN NN I-SpecificDisease
dehydrogenase NN NN I-SpecificDisease
deficiency NN NN I-SpecificDisease
. NN NN O

Cloning NN NN O
of NN NN O
a NN NN O
novel NN NN O
member NN NN O
of NN NN O
the NN NN O
low-density NN NN O
lipoprotein NN NN O
receptor NN NN O
family NN NN O
. NN NN O

The NN NN O
APC NN NN B-Modifier
variants NN NN O
I1307K NN NN O
and NN NN O
E1317Q NN NN O
are NN NN O
associated NN NN O
with NN NN O
colorectal NN NN B-DiseaseClass
tumors NN NN I-DiseaseClass
, NN NN O
but NN NN O
not NN NN O
always NN NN O
with NN NN O
a NN NN O
family NN NN O
history NN NN O
. NN NN O

Genomic NN NN O
structure NN NN O
of NN NN O
the NN NN O
human NN NN O
congenital NN NN B-Modifier
chloride NN NN I-Modifier
diarrhea NN NN I-Modifier
( NN NN O
CLD NN NN B-Modifier
) NN NN O
gene NN NN O
. NN NN O

The NN NN O
APCI1307K NN NN O
allele NN NN O
and NN NN O
cancer NN NN B-Modifier
risk NN NN O
in NN NN O
a NN NN O
community-based NN NN O
study NN NN O
of NN NN O
Ashkenazi NN NN O
Jews NN NN O
. NN NN O

Sperm NN NN O
DNA NN NN O
analysis NN NN O
in NN NN O
a NN NN O
Friedreich NN NN B-Modifier
ataxia NN NN I-Modifier
premutation NN NN O
carrier NN NN O
suggests NN NN O
both NN NN O
meiotic NN NN O
and NN NN O
mitotic NN NN O
expansion NN NN O
in NN NN O
the NN NN O
FRDA NN NN B-Modifier
gene NN NN O
. NN NN O

The NN NN O
R496H NN NN O
mutation NN NN O
of NN NN O
arylsulfatase NN NN O
A NN NN O
does NN NN O
not NN NN O
cause NN NN O
metachromatic NN NN B-SpecificDisease
leukodystrophy NN NN I-SpecificDisease
. NN NN O

Down-regulation NN NN O
of NN NN O
transmembrane NN NN O
carbonic NN NN O
anhydrases NN NN O
in NN NN O
renal NN NN B-Modifier
cell NN NN I-Modifier
carcinoma NN NN I-Modifier
cell NN NN O
lines NN NN O
by NN NN O
wild-type NN NN O
von NN NN B-Modifier
Hippel-Lindau NN NN I-Modifier
transgenes NN NN O
. NN NN O

A NN NN O
gene NN NN O
encoding NN NN O
a NN NN O
transmembrane NN NN O
protein NN NN O
is NN NN O
mutated NN NN O
in NN NN O
patients NN NN O
with NN NN O
diabetes NN NN B-SpecificDisease
mellitus NN NN I-SpecificDisease
and NN NN O
optic NN NN B-SpecificDisease
atrophy NN NN I-SpecificDisease
( NN NN O
Wolfram NN NN B-SpecificDisease
syndrome NN NN I-SpecificDisease
). NN NN O

Stable NN NN O
interaction NN NN O
between NN NN O
the NN NN O
products NN NN O
of NN NN O
the NN NN O
BRCA1 NN NN O
and NN NN O
BRCA2 NN NN O
tumor NN NN B-Modifier
suppressor NN NN O
genes NN NN O
in NN NN O
mitotic NN NN O
and NN NN O
meiotic NN NN O
cells NN NN O
. NN NN O

A NN NN O
novel NN NN O
Arg362Ser NN NN O
mutation NN NN O
in NN NN O
the NN NN O
sterol NN NN O
27-hydroxylase NN NN O
gene NN NN O
( NN NN O
CYP27 NN NN O
): NN NN O
its NN NN O
effects NN NN O
on NN NN O
pre-mRNA NN NN O
splicing NN NN O
and NN NN O
enzyme NN NN O
activity NN NN O
. NN NN O

ATM NN NN O
germline NN NN O
mutations NN NN O
in NN NN O
classical NN NN O
ataxia-telangiectasia NN NN B-Modifier
patients NN NN O
in NN NN O
the NN NN O
Dutch NN NN O
population NN NN O
. NN NN O

Determination NN NN O
of NN NN O
the NN NN O
genomic NN NN O
structure NN NN O
of NN NN O
the NN NN O
COL4A4 NN NN O
gene NN NN O
and NN NN O
of NN NN O
novel NN NN O
mutations NN NN O
causing NN NN O
autosomal NN NN B-SpecificDisease
recessive NN NN I-SpecificDisease
Alport NN NN I-SpecificDisease
syndrome NN NN I-SpecificDisease
. NN NN O

Founder NN NN O
BRCA1 NN NN O
and NN NN O
BRCA2 NN NN O
mutations NN NN O
in NN NN O
French NN NN O
Canadian NN NN O
breast NN NN B-Modifier
and NN NN I-Modifier
ovarian NN NN I-Modifier
cancer NN NN I-Modifier
families NN NN O
. NN NN O

Are NN NN O
Dp71 NN NN O
and NN NN O
Dp140 NN NN O
brain NN NN O
dystrophin NN NN O
isoforms NN NN O
related NN NN O
to NN NN O
cognitive NN NN B-DiseaseClass
impairment NN NN I-DiseaseClass
in NN NN O
Duchenne NN NN B-SpecificDisease
muscular NN NN I-SpecificDisease
dystrophy NN NN I-SpecificDisease
? NN NN O

I1307K NN NN O
APC NN NN O
and NN NN O
hMLH1 NN NN O
mutations NN NN O
in NN NN O
a NN NN O
non-Jewish NN NN O
family NN NN O
with NN NN O
hereditary NN NN B-SpecificDisease
non-polyposis NN NN I-SpecificDisease
colorectal NN NN I-SpecificDisease
cancer NN NN I-SpecificDisease
. NN NN O

Identification NN NN O
of NN NN O
a NN NN O
novel NN NN O
mutation NN NN O
of NN NN O
the NN NN O
CPO NN NN O
gene NN NN O
in NN NN O
a NN NN O
Japanese NN NN O
hereditary NN NN B-Modifier
coproporphyria NN NN I-Modifier
family NN NN O
. NN NN O

Human NN NN B-SpecificDisease
complement NN NN I-SpecificDisease
factor NN NN I-SpecificDisease
H NN NN I-SpecificDisease
deficiency NN NN I-SpecificDisease
associated NN NN O
with NN NN O
hemolytic NN NN B-SpecificDisease
uremic NN NN I-SpecificDisease
syndrome NN NN I-SpecificDisease
. NN NN O

Further NN NN O
evidence NN NN O
for NN NN O
a NN NN O
major NN NN O
ancient NN NN O
mutation NN NN O
underlying NN NN O
myotonic NN NN B-SpecificDisease
dystrophy NN NN I-SpecificDisease
from NN NN O
linkage NN NN O
disequilibrium NN NN O
studies NN NN O
in NN NN O
the NN NN O
Japanese NN NN O
population NN NN O
. NN NN O

The NN NN O
molecular NN NN O
basis NN NN O
of NN NN O
C6 NN NN B-SpecificDisease
deficiency NN NN I-SpecificDisease
in NN NN O
the NN NN O
western NN NN O
Cape NN NN O
, NN NN O
South NN NN O
Africa NN NN O
. NN NN O

Complement NN NN B-SpecificDisease
C7 NN NN I-SpecificDisease
deficiency NN NN I-SpecificDisease
: NN NN O
seven NN NN O
further NN NN O
molecular NN NN O
defects NN NN O
and NN NN O
their NN NN O
associated NN NN O
marker NN NN O
haplotypes NN NN O
. NN NN O

A NN NN O
genome-wide NN NN O
search NN NN O
for NN NN O
chromosomal NN NN O
loci NN NN O
linked NN NN O
to NN NN O
mental NN NN O
health NN NN O
wellness NN NN O
in NN NN O
relatives NN NN O
at NN NN O
high NN NN O
risk NN NN O
for NN NN O
bipolar NN NN B-SpecificDisease
affective NN NN I-SpecificDisease
disorder NN NN I-SpecificDisease
among NN NN O
the NN NN O
Old NN NN O
Order NN NN O
Amish NN NN O
. NN NN O

Segregation NN NN O
distortion NN NN O
in NN NN O
myotonic NN NN B-SpecificDisease
dystrophy NN NN I-SpecificDisease
. NN NN O

Diagnosis NN NN O
of NN NN O
hemochromatosis NN NN B-SpecificDisease
. NN NN O

Prevalence NN NN O
of NN NN O
the NN NN O
I1307K NN NN O
APC NN NN B-Modifier
gene NN NN O
variant NN NN O
in NN NN O
Israeli NN NN O
Jews NN NN O
of NN NN O
differing NN NN O
ethnic NN NN O
origin NN NN O
and NN NN O
risk NN NN O
for NN NN O
colorectal NN NN B-SpecificDisease
cancer NN NN I-SpecificDisease
. NN NN O

Systematic NN NN O
analysis NN NN O
of NN NN O
coproporphyrinogen NN NN O
oxidase NN NN O
gene NN NN O
defects NN NN O
in NN NN O
hereditary NN NN B-SpecificDisease
coproporphyria NN NN I-SpecificDisease
and NN NN O
mutation NN NN O
update NN NN O
. NN NN O

Coincidence NN NN O
of NN NN O
two NN NN O
novel NN NN O
arylsulfatase NN NN O
A NN NN O
alleles NN NN O
and NN NN O
mutation NN NN O
459+1G>A NN NN O
within NN NN O
a NN NN O
family NN NN O
with NN NN O
metachromatic NN NN B-SpecificDisease
leukodystrophy NN NN I-SpecificDisease
: NN NN O
molecular NN NN O
basis NN NN O
of NN NN O
phenotypic NN NN O
heterogeneity NN NN O
. NN NN O

Human NN NN O
MLH1 NN NN O
deficiency NN NN O
predisposes NN NN O
to NN NN O
hematological NN NN B-DiseaseClass
malignancy NN NN I-DiseaseClass
and NN NN O
neurofibromatosis NN NN B-SpecificDisease
type NN NN I-SpecificDisease
1 NN NN I-SpecificDisease
. NN NN O

Missense NN NN O
mutations NN NN O
in NN NN O
the NN NN O
most NN NN O
ancient NN NN O
residues NN NN O
of NN NN O
the NN NN O
PAX6 NN NN O
paired NN NN O
domain NN NN O
underlie NN NN O
a NN NN O
spectrum NN NN O
of NN NN O
human NN NN O
congenital NN NN B-DiseaseClass
eye NN NN I-DiseaseClass
malformations NN NN I-DiseaseClass
. NN NN O

The NN NN O
chromosomal NN NN O
order NN NN O
of NN NN O
genes NN NN O
controlling NN NN O
the NN NN O
major NN NN O
histocompatibility NN NN O
complex NN NN O
, NN NN O
properdin NN NN O
factor NN NN O
B NN NN O
, NN NN O
and NN NN O
deficiency NN NN B-SpecificDisease
of NN NN I-SpecificDisease
the NN NN I-SpecificDisease
second NN NN I-SpecificDisease
component NN NN I-SpecificDisease
of NN NN I-SpecificDisease
complement NN NN I-SpecificDisease
. NN NN O

Distribution NN NN O
of NN NN O
emerin NN NN O
and NN NN O
lamins NN NN O
in NN NN O
the NN NN O
heart NN NN O
and NN NN O
implications NN NN O
for NN NN O
Emery-Dreifuss NN NN B-SpecificDisease
muscular NN NN I-SpecificDisease
dystrophy NN NN I-SpecificDisease
. NN NN O

Genetic NN NN O
mapping NN NN O
of NN NN O
the NN NN O
copper NN NN B-Modifier
toxicosis NN NN I-Modifier
locus NN NN O
in NN NN O
Bedlington NN NN O
terriers NN NN O
to NN NN O
dog NN NN O
chromosome NN NN O
10 NN NN O
, NN NN O
in NN NN O
a NN NN O
region NN NN O
syntenic NN NN O
to NN NN O
human NN NN O
chromosome NN NN O
region NN NN O
2p13-p16 NN NN O
. NN NN O

Molecular NN NN O
analysis NN NN O
of NN NN O
the NN NN O
APC NN NN B-Modifier
gene NN NN O
in NN NN O
205 NN NN O
families NN NN O
: NN NN O
extended NN NN O
genotype-phenotype NN NN O
correlations NN NN O
in NN NN O
FAP NN NN B-SpecificDisease
and NN NN O
evidence NN NN O
for NN NN O
the NN NN O
role NN NN O
of NN NN O
APC NN NN B-Modifier
amino NN NN O
acid NN NN O
changes NN NN O
in NN NN O
colorectal NN NN B-Modifier
cancer NN NN I-Modifier
predisposition NN NN O
. NN NN O

Inherited NN NN B-SpecificDisease
colorectal NN NN I-SpecificDisease
polyposis NN NN I-SpecificDisease
and NN NN O
cancer NN NN B-Modifier
risk NN NN O
of NN NN O
the NN NN O
APC NN NN O
I1307K NN NN O
polymorphism NN NN O
. NN NN O

Localization NN NN O
of NN NN O
human NN NN O
BRCA1 NN NN O
and NN NN O
its NN NN O
loss NN NN O
in NN NN O
high-grade NN NN O
, NN NN O
non-inherited NN NN B-SpecificDisease
breast NN NN I-SpecificDisease
carcinomas NN NN I-SpecificDisease
. NN NN O

